Market revenue in 2023 | USD 80.2 million |
Market revenue in 2030 | USD 163.9 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Regenerative medicine |
Fastest growing segment | Drug Discovery & Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regenerative Medicine, Drug Discovery & Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.4% in 2023. Horizon Databook has segmented the Latin America human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
This region is expected to witness growth owing to rise in the adoption by the scientists and physicians for cell therapies. Stem cell research carried out in countries such as Brazil, Uruguay, Chile, and Argentina is anticipated to drive regional growth.
Changes in the regulatory policies restrict the human embryonic stem cell market. The market growth is limited to developing countries such as Brazil that has taken step forward to conduct research in the field but restricted the use and application in therapeutic purposes.
Stem cell research has been defined as a priority research area in many Latin American countries. Latin American countries also share concerns toward unproven stem cell treatments and regulatory loopholes or absence of regulation.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America human embryonic stem cells market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account